Evidence map›Paper›PMID 38520659›Full record

ArticleInternational journal of hematology2024

Platelet and large platelet ratios are useful in predicting severity of COVID-19.

Hisae Sugihara, Atsushi Marumo, Haruka Okabe, Kiyotaka Kohama, Takashi Mera, Eriko Morishita

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of hematology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Development and validation of nomogram for predicting the risk of transferring to the ICU for children with influenza.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hisae Sugihara *Division of Clinical Laboratory, Fussa Hospital, Fussa, Tokyo, Japan.
Atsushi Marumo *Division of Internal Medicine, Fussa Hospital, 1-6-1 Kamidaira, Fussa, Tokyo, 197-8511, Japan. a.agassi2112@gmail.com.ORCID http://orcid.org/0000-0001-6849-9117
Haruka OkabeDivision of Internal Medicine, Fussa Hospital, 1-6-1 Kamidaira, Fussa, Tokyo, 197-8511, Japan.
Kiyotaka KohamaDivision of Internal Medicine, Fussa Hospital, 1-6-1 Kamidaira, Fussa, Tokyo, 197-8511, Japan.
Takashi MeraDivision of Clinical Laboratory, Fussa Hospital, Fussa, Tokyo, Japan.
Eriko MorishitaDepartment of Hematology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The role of platelets in coronavirus disease (COVID-19) severity requires further exploration. To determine whether the platelet index is useful in predicting COVID-19 severity, we compared the platelet index in patients with higher and lower oxygen requirements (≥ 4 L/min vs. < 4 L/min) and patients without COVID-19. We also analyzed the time course of the platelet index in each group. A total of 285 patients with COVID-19 and 36 without COVID-19 who were hospitalized at Fussa Hospital were analyzed. After matching for oxygen requirement at admission, multivariate analysis was performed. Platelets (≤ 16.6 × 10

Indexed as

Blood PlateletsCOVID-19SARS-CoV-2Severity of Illness IndexAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedPlatelet CountPrognosisRetrospective StudiesCOVID-19Platelet indexPlatelet-large cell ratioPrognostic factorRisk-prediction score

Identifiers

PMID38520659

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.